Lioprime

$19.00

Manufacturer: Eminence Labs
Substance: Liothyronine (T3)
Package: 25mcg/tab. (50 tabs)

Category:

Description

General information about T3 Greece in Italy

Cytomel, T3 (triiodothyronine) is not an anabolic steroid, it is a thyroid hormone and speeds up metabolism causing faster conversion of carbohydrates, proteins and fats. chemical action: liothyronine sodium. Cytomel: a brand name drug liothyronine sodium. This is not an anabolic and thyroid hormone. In medicine it is used in cases of thyroid disease, obesity, metabolic diseases and fatigue. More specifically, this means a pharmaceutical product, made from the natural thyroid hormone, triiodothyronine (T-3). Receiving Cytomel accelerates the metabolism of patients. As a result, cell activity increases, which is expressed in faster processing of carbohydrates, fats and proteins. It is good for athletes because it helps burn excess body fat.

Characteristics T3 Greece in Italy

If you plan to use this product, you must be very cautious and careful, as there are a large number of warnings and contraindications to receiving Cytomel, which cannot be ignored. The list of side effects includes (but is not limited to) palpitations, agitation, breath holding, arrhythmia, sweating, nausea, headache, and metabolic disturbances. This is the powerful hormone, and when used incorrectly, it can lead to serious violations in the body. If you take Cytomel, remember that your dose must be increased very slowly. Usually the first day you take 1 25 mg tablet, then increase the dose, also taking one tablet every 3 or 4 days, leading to a maximum dose of 100 mcg. This mode allows the body to adjust to rising thyroid hormone levels and avoid disruptions.

Buy T3 Greece

Dosage: It is important to note that the entire cycle should not exceed 6 weeks and cannot be stopped abruptly. The dose should be reduced as slowly (to 1 tablet every 3-4 days) as it is increased.

Reviews

There are no reviews yet.

Be the first to review “Lioprime”

Your email address will not be published. Required fields are marked *